Dr. Wyatt McDonnell is Co-Founder and CEO at Infinimmune, a biotechnology company utilizing natural immunity to transform natural antibodies into safer and more effective drugs for complex diseases. Previously, McDonnell developed 10x Genomics’ first therapeutic antibodies and core immunology IP behind three commercial products to interrogate the immune repertoire. He has co-authored 31 peer-reviewed papers, published 19 patents, and spoken at several revered industry conferences.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)